[1]
|
史玉玲, 陈文娟. 银屑病共病的现状及诊治[J]. 诊断学理论与实践, 2023, 22(3): 221-229.
|
[2]
|
王宁, 王思农, 牛凡琪, 等. 银屑病相关信号通路的中药调控研究进展[J]. 辽宁中医药大学学报, 2024: 1-20.
|
[3]
|
Feng, S., Wang, L., Liu, W., Zhong, Y. and Xu, S. (2018) MiR-126 Correlates with Increased Disease Severity and Promotes Keratinocytes Proliferation and Inflammation While Suppresses Cells’ Apoptosis in Psoriasis. Journal of Clinical Laboratory Analysis, 32, e22588. https://doi.org/10.1002/jcla.22588
|
[4]
|
Kuczyńska, M., Gabig-Cimińska, M. and Moskot, M. (2023) Molecular Treatment Trajectories within Psoriatic T Lymphocytes: A Mini Review. Frontiers in Immunology, 14, Article ID: 1170273. https://doi.org/10.3389/fimmu.2023.1170273
|
[5]
|
Servitje, O., Bordas, X., Seron, D., et al. (1996) Changes in T-Cell Phenotype and Adhesion Molecules Expression in Psoriatic Lesions after Low-Dose Cyclosporin Therapy. Journal of Cutaneous Pathology, 23, 431-436. https://doi.org/10.1111/j.1600-0560.1996.tb01432.x
|
[6]
|
杨艳妮, 赵子葳, 李新华. 丝裂原活化蛋白激酶信号通路在寻常型银屑病发病机制中的研究进展[J]. 实用临床医药杂志, 2022, 26(18): 136-139.
|
[7]
|
Shi, Y.L., Chen, Z.Y., Zhao, Z.H., et al. (2019) IL-21 Induces an Imbalance of Th17/Treg Cells in Moderate-to-Severe Plaque Psoriasis Patients. Frontiers in Immunology, 10, Article No. 1865. https://doi.org/10.3389/fimmu.2019.01865
|
[8]
|
刘凤杰, 栗玉珍. MAPK信号通路及STAT3、STAT5A/B在银屑病皮损中表达增高[J]. 实用医学杂志, 2018, 34(18): 3020-3023.
|
[9]
|
Guo, J., Zhang, H., Lin, W., Lu, L., Su, J. and Chen, X. (2023) Signaling Pathways and Targeted Therapies for Psoriasis. Signal Transduction and Targeted Therapy, 8, 437. https://doi.org/10.1038/s41392-023-01655-6
|
[10]
|
Qi, X.M. and Chen, G. (2023) 38γ MAPK Inflammatory and Metabolic Signaling in Physiology and Disease. Cells, 12, Article No. 1674. https://doi.org/10.3390/cells12131674
|
[11]
|
Kim, E.K. and Choi, E.J. (2010) Pathological Roles of MAPK Signaling Pathways in Human Diseases. Biochimica et Biophysica Acta, 1802, 396-405. https://doi.org/10.1016/j.bbadis.2009.12.009
|
[12]
|
Mavropoulos, A., Rigopoulou, E.I., Liaskos, C., et al. (2013) The Role of P38 MAPK in the Aetiopathogenesis of Psoriasis and Psoriatic Arthritis. Clinical and Developmental Immunology, 2013, Article ID: 569751. https://doi.org/10.1155/2013/569751
|
[13]
|
Ni, X., Xu, Y., Wang, W., et al. (2022) IL-17D-Induced Inhibition of DDX5 Expression in Keratinocytes Amplifies IL-36R-Mediated Skin Inflammation. Nature Immunology, 23, 1577-1587. https://doi.org/10.1038/s41590-022-01339-3
|
[14]
|
Bertelsen, T., Iversen, L. and Johansen, C. (2018) The Human IL-17A/F Heterodimer Regulates Psoriasis-Associated Genes through IκBζ. Experimental Dermatology, 27, 1048-1052. https://doi.org/10.1111/exd.13722
|
[15]
|
Guo, H., Li, M. and Liu, H. (2022) Selenium-Rich Yeast Peptide Fraction Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis in Mice by Inhibiting Inflammation via MAPK and NF-κB Signaling Pathways. International Journal of Molecular Sciences, 23, Article No. 2112. https://doi.org/10.3390/ijms23042112
|
[16]
|
Lin, Z.M., Ma, M., Li, H., et al. (2018) Topical Administration of Reversible SAHH Inhibitor Ameliorates Imiquimod-Induced Psoriasis-Like Skin Lesions in Mice via Suppression of TNF-α/IFN-γ-Induced Inflammatory Response in Keratinocytes and T Cell-Derived IL-17. Pharmacological Research, 129, 443-452. https://doi.org/10.1016/j.phrs.2017.11.012
|
[17]
|
Lei, H., Li, X., Jing, B., et al. (2017) Human S100A7 Induces Mature Interleukin1α Expression by RAGE-P38 MAPK-Calpain1 Pathway in Psoriasis. PLOS ONE, 12, E0169788. https://doi.org/10.1371/journal.pone.0169788
|
[18]
|
Yu, J., Xiao, Z., Zhao, R., et al. (2018) Astilbin Emulsion Improves Guinea Pig Lesions in a Psoriasis-Like Model by Suppressing IL-6 and IL-22 via P38 MAPK. Molecular Medicine Reports, 17, 3789-3796. https://doi.org/10.3892/mmr.2017.8343
|
[19]
|
Pang, W., Qi, X., Cao, C., et al. (2018) Inhibitory Effects of TGP on KGF-Induced Hyperproliferation of HaCaT Cells via Suppression of the P38 MAPK/NF-κB P65 Pathway. Molecular Medicine Reports, 18, 2207-2215. https://doi.org/10.3892/mmr.2018.9177
|
[20]
|
杭小涵, 李雪, 李楠, 等. 基于P38MAPK/NF-κB信号通路探讨外用应急软膏治疗银屑病的机制研究[J]. 世界临床药物, 2023, 44(3): 215-219 251.
|
[21]
|
Torales-Cardena, A., Martines-Tottes, I., Rodriguez, S., et al. (2015) Cross Talk between Proliferative, Angiogenic, and Cellular Mechanisms Orchestred by HIF-1α in Psoriasis. Mediators of Inflammation, 2015, Article ID: 607363. https://doi.org/10.1155/2015/607363
|
[22]
|
Mose, M., Kang, Z., Raaby, L., Iversen, L. and Johansen, C. (2013) TNFα-and IL-17A-Mediated S100 A 8 Expression Is Regulated by p38 MAPK. Experimental Dermatology, 22, 476-481. https://doi.org/10.1111/exd.12187
|
[23]
|
Kanemaru, K., Nakamura, Y., Totoki, K., et al. (2017) Phospholipase Cδ1 Regulates P38 MAPK Activity and Skin Barrier Integrity. Cell Death & Differentiation, 24, 1079-1090. https://doi.org/10.1038/cdd.2017.56
|
[24]
|
Gaestel, M. (2016) MAPK-Activated Protein Kinases (MKs): Novel Insights and Challenges. Frontiers in Cell and Developmental Biology, 3, Article No. 88. https://doi.org/10.3389/fcell.2015.00088
|
[25]
|
Yu, X.J., Li, C.Y., Dai, H.Y., et al. (2007) Expression and Localization of the Activated Mitogen-Activated Protein Kinase in Lesional Psoriatic Skin. Experimental and Molecular Pathology, 83, 413-418. https://doi.org/10.1016/j.yexmp.2007.05.002
|
[26]
|
Huang, X.L., Yu, P.X., Liu, M.Y., et al. (2019) ERK Inhibitor JSI287 Alleviates Imiquimod-Induced Mice Skin Lesions by ERK/IL-17 Signaling Pathway. International Immunopharmacology, 66, 236-241. https://doi.org/10.1016/j.intimp.2018.11.031
|
[27]
|
Ren, K. and Xia, Y. (2022) Lipocalin 2 Participates in the Epidermal Differentiation and Inflammatory Processes of Psoriasis. Journal of Inflammation Research, 15, 2157-2166. https://doi.org/10.2147/JIR.S358492
|
[28]
|
Wang, Y., Han, D., Huang, Y., et al. (2024) Oral Administration of Punicalagin Attenuates Imiquimod-Induced Psoriasis by Reducing ROS Generation and Inflammation via MAPK/ERK and NF-κB Signaling Pathways. Phytotherapy Research, 38, 713-726. https://doi.org/10.1002/ptr.8071
|
[29]
|
Tu, Z., Wei, W., Zeng, F., et al. (2024) IL-6 Up-Regulates Expression of LIM-Domain Only Protein 4 in Psoriatic Keratinocytes through Activation of the MEK/ERK/NF-κB Pathway. The American Journal of Pathology. https://doi.org/10.1016/j.ajpath.2024.01.014
|
[30]
|
Wu, Y., Liu, L., Bian, C.X., et al. (2018) MicroRNA Let-7b Inhibits Keratinocyte Differentiation by Targeting IL-6 Mediated ERK Signaling in Psoriasis. Cell Communication and Signaling, 16, Article No. 58. https://doi.org/10.1186/s12964-018-0271-9
|
[31]
|
Jiang, M., Li, B., Zhang, J., et al. (2017) Vascular Endothelial Growth Factor Driving Aberrant Keratin Expression Pattern Contributes to the Pathogenesis of Psoriasis. Experimental Cell Research, 360, 310-319. https://doi.org/10.1016/j.yexcr.2017.09.021
|
[32]
|
罗小梅, 程志勇, 韩晓群, 等. VEGF⁃VEGFR2信号通路在银屑病中作用的研究进展[J]. 皮肤性病诊疗学杂志, 2022, 29(5): 482-486.
|
[33]
|
Furue, K., Ito, T., Tanaka, Y., et al. (2020) The EGFR-ERK/JNK-CCL20 Pathway in Scratched Keratinocytes May Underpin Koebnerization in Psoriasis Patients. International Journal of Molecular Sciences, 21, Article No. 434. https://doi.org/10.3390/ijms21020434
|
[34]
|
葛新红, 唐真真, 焦亚宁, 等. 磷酸化C-Jun氨基末端激酶和P38丝裂原活化蛋白激酶在寻常性银屑病皮损中的表达[J]. 中华皮肤科杂志, 2016, 49(4): 248-251.
|
[35]
|
Hammouda, M.B., Ford, A.E., Liu, Y., et al. (2020) The JNK Signaling Pathway in Inflammatory Skin Disorders and Cancer. Cells, 9, Article No. 857. https://doi.org/10.3390/cells9040857
|
[36]
|
Li, H. and Huo, R. (2017) Cyr61/CCN1 Induces CCL20 Production by Keratinocyte via Activating P38 and JNK/AP-1 Pathway in Psoriasis. Journal of Dermatological Science, 88, 46-56. https://doi.org/10.1016/j.jdermsci.2017.05.018
|
[37]
|
Novoszel, P., Holcmann, M., Stulnig, G., et al. (2021) Psoriatic Skin Inflammation Is Promoted by C-Jun/AP-1-Dependent CCL2 and IL-23 Expression in Dendritic Cells. EMBO Molecular Medicine, 13, E12409. https://doi.org/10.15252/emmm.202012409
|
[38]
|
Kanda, N., Kamata, M., Tada, Y., et al. (2011) Human β-Defensin-2 Enhances IFN-γ and IL-10 Production and Suppresses IL-17 Production in T Cells. Journal of Leukocyte Biology, 89, 935-944. https://doi.org/10.1189/jlb.0111004
|
[39]
|
高丽, 王俊伟, 杨宇辉. 寻常性银屑病马拉色菌感染与相关细胞因子的关系[J]. 中华医院感染学杂志, 2023, 33(21): 3284-3287.
|
[40]
|
Afonina, I.S., Van Nuffel, E., Baudelet, G., et al. (2016) The Paracaspase MALT1 Mediates CARD14-Induced Signaling in Keratinocytes. EMBO Reports, 17, 914-927. https://doi.org/10.15252/embr.201642109
|
[41]
|
Gao, L., Li, K., Li, F., et al. (2010) Polymorphisms in the FOXP3 Gene in Han Chinese Psoriasis Patients. Journal of Dermatological Science, 57, 51-56. https://doi.org/10.1016/j.jdermsci.2009.09.010
|
[42]
|
Arasa, J., Terencio, M.C., Andrés, R.M., et al. (2019) Defective Induction of COX-2 Expression by Psoriatic Fibroblasts Promotes Pro-Inflammatory Activation of Macrophages. Frontiers in Immunology, 10, Article No. 536. https://doi.org/10.3389/fimmu.2019.00536
|
[43]
|
Shi, Z.R., Tan, G.Z., Cao, C.X., et al. (2018) Decrease of Galectin-3 in Keratinocytes: A Potential Diagnostic Marker and a Critical Contributor to the Pathogenesis of Psoriasis. Journal of Autoimmunity, 89, 30-40. https://doi.org/10.1016/j.jaut.2017.11.002
|
[44]
|
Rizaldy, D., Toriyama, M., Kato, H., et al. (2021) Increase in Primary Cilia in the Epidermis of Patients with Atopic Dermatitis and Psoriasis. Experimental Dermatology, 30, 792-803. https://doi.org/10.1111/exd.14285
|
[45]
|
Liang, J., Chen, P., Li, C., et al. (2019) IL-22 Down-Regulates Cx43 Expression and Decreases Gap Junctional Intercellular Communication by Activating the JNK Pathway in Psoriasis. Journal of Investigative Dermatology, 33, 1144-1148. https://doi.org/10.1016/j.jid.2018.07.032
|
[46]
|
Yu, X.J., Li, C.Y., Xu, Y.H., et al. (2009) Calcitonin Gene-Related Peptide Increases Proliferation of Human HaCaT Keratinocytes by Activation of MAP Kinases. Cell Biology International, 33, 1144-1148. https://doi.org/10.1016/j.cellbi.2009.07.003
|
[47]
|
Theoharides, T.C., Zhang, B., Kempuraj, D., et al. (2010) IL-33 Augments Substance P-Induced VEGF Secretion from Human Mast Cells and Is Increased in Psoriatic Skin. Proceedings of the National Academy of Sciences of the United States of America, 107, 4448-4453. https://doi.org/10.1073/pnas.1000803107
|
[48]
|
万新, 曾三武. 单味中药调控MAPK信号通路在银屑病中的研究进展[J]. 中成药, 2023, 45(8): 2650-2656.
|
[49]
|
Saklatvala, J. (2004) The P38 MAP Kinase Pathway as a Therapeutic Target in Inflammatory Disease. Current Opinion in Pharmacology, 4, 372-377. https://doi.org/10.1016/j.coph.2004.03.009
|
[50]
|
Honma, M. and Hayashi, K. (2021) Psoriasis: Recent Progress in Molecular-Targeted Therapies. The Journal of Dermatology, 48, 761-777. https://doi.org/10.1111/1346-8138.15727
|